An international study identifies distinct gut microbiota linked to interstitial lung disease in systemic sclerosis, ...
The diffuse cutaneous systemic sclerosis market landscape is evolving from conventional symptom-focused strategies toward therapies that specifically target fibrosis and immune modulation, addressing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback